Suppr超能文献

加巴喷丁与三环类抗抑郁药治疗糖尿病性神经病变和带状疱疹后神经痛:随机对照试验直接和间接荟萃分析之间的差异

Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials.

作者信息

Chou Roger, Carson Susan, Chan Benjamin K S

机构信息

Oregon Evidence-based Practice Center, 3181 SW Sam Jackson Park Road, Mail code: BICC, Portland, OR 97239, USA.

出版信息

J Gen Intern Med. 2009 Feb;24(2):178-88. doi: 10.1007/s11606-008-0877-5. Epub 2008 Dec 17.

Abstract

BACKGROUND

Previous systematic reviews concluded that tricyclics antidepressants are superior to gabapentin for neuropathic pain, but were based on indirect comparisons from placebo-controlled trials.

PURPOSE

To evaluate gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia, using direct and indirect comparisons.

DATA SOURCES

MEDLINE (1966 to March Week 4 2008), the Cochrane central register of controlled trials (1st quarter 2008), and reference lists.

STUDY SELECTION

We selected randomized trials directly comparing gabapentin versus tricyclic antidepressants or comparing either of these medications versus placebo.

DATA EXTRACTION

Studies were reviewed, abstracted, and quality-rated by two independent investigators using predefined criteria.

DATA SYNTHESIS

We performed a meta-analysis of head-to-head trials using a random effects model and compared the results to an adjusted indirect analysis of placebo-controlled trials.

RESULTS

In three head-to-head trials, there was no difference between gabapentin and tricyclic antidepressants for achieving pain relief (RR 0.99, 95% CI 0.76 to 1.29). In adjusted indirect analyses, gabapentin was worse than tricyclic antidepressants for achieving pain relief (RR = 0.41, 95% CI 0.23 to 0.74). The discrepancy between direct and indirect analyses was statistically significant (p = 0.008). Placebo-controlled tricyclic trials were conducted earlier than the gabapentin trials, reported lower placebo response rates, had more methodological shortcomings, and were associated with funnel plot asymmetry.

CONCLUSIONS

Though direct evidence is limited, we found no difference in likelihood of achieving pain relief between gabapentin and tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia. Indirect analyses that combine data from sets of trials conducted in different eras can be unreliable.

摘要

背景

以往的系统评价得出结论,三环类抗抑郁药在治疗神经性疼痛方面优于加巴喷丁,但这些结论基于安慰剂对照试验的间接比较。

目的

采用直接和间接比较的方法,评估加巴喷丁与三环类抗抑郁药治疗糖尿病性神经病变和带状疱疹后神经痛的疗效。

数据来源

MEDLINE(1966年至2008年第3周)、Cochrane对照试验中心注册库(2008年第1季度)及参考文献列表。

研究选择

我们选取了直接比较加巴喷丁与三环类抗抑郁药或比较这两种药物与安慰剂的随机试验。

数据提取

由两名独立研究人员按照预先设定的标准对研究进行审查、提取摘要并进行质量评级。

数据综合

我们采用随机效应模型对直接对比试验进行荟萃分析,并将结果与安慰剂对照试验的校正间接分析结果进行比较。

结果

在三项直接对比试验中,加巴喷丁与三环类抗抑郁药在实现疼痛缓解方面无差异(相对危险度0.99,95%可信区间0.76至1.29)。在校正间接分析中,加巴喷丁在实现疼痛缓解方面比三环类抗抑郁药差(相对危险度 = 0.41,95%可信区间0.23至0.74)。直接分析与间接分析之间的差异具有统计学意义(p = 0.008)。安慰剂对照的三环类药物试验比加巴喷丁试验开展得更早,报告的安慰剂反应率更低,存在更多方法学缺陷,且与漏斗图不对称有关。

结论

尽管直接证据有限,但我们发现加巴喷丁与三环类抗抑郁药在治疗糖尿病性神经病变和带状疱疹后神经痛时,实现疼痛缓解的可能性没有差异。合并不同时期进行的试验组数据的间接分析可能不可靠。

相似文献

2
Nortriptyline for neuropathic pain in adults.
Cochrane Database Syst Rev. 2015 Jan 8;1(1):CD011209. doi: 10.1002/14651858.CD011209.pub2.
3
Gabapentin versus tricyclics for neuropathic pain.
J Gen Intern Med. 2009 Jun;24(6):780-1; author reply 782. doi: 10.1007/s11606-009-0957-1.
4
Interventions for Neuropathic Pain: An Overview of Systematic Reviews.
Anesth Analg. 2017 Aug;125(2):643-652. doi: 10.1213/ANE.0000000000001998.
5
Gabapentin for Chronic Neuropathic Pain.
JAMA. 2018 Feb 27;319(8):818-819. doi: 10.1001/jama.2017.21547.
6
Pregabalin: new drug. Very similar to gabapentin.
Prescrire Int. 2005 Dec;14(80):203-6.
7
Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.
Clin Ther. 2003 Jan;25(1):81-104. doi: 10.1016/s0149-2918(03)90011-7.
8
[Evidence-based pharmacotherapy of neuropathic pain syndromes].
MMW Fortschr Med. 2004 Dec 9;146(50):49-51.
10
Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
Cochrane Database Syst Rev. 2017 Aug 5;8(8):CD012536. doi: 10.1002/14651858.CD012536.pub2.

引用本文的文献

1
Updating the Comparative Evidence on Second-Generation Antipsychotic Use With Schizophrenia.
Psychiatr Res Clin Pract. 2020 Oct 16;2(2):76-87. doi: 10.1176/appi.prcp.20200004. eCollection 2020 Dec.
2
Neuropathy in Human Immunodeficiency Virus: A Review of the Underlying Pathogenesis and Treatment.
Cureus. 2022 Jun 13;14(6):e25905. doi: 10.7759/cureus.25905. eCollection 2022 Jun.
3
Pharmacotherapy of Painful Diabetic Neuropathy: A Clinical Update.
Sisli Etfal Hastan Tip Bul. 2022 Mar 28;56(1):1-20. doi: 10.14744/SEMB.2021.54670. eCollection 2022.
5
Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs.
Drugs. 2020 Mar;80(4):363-384. doi: 10.1007/s40265-020-01259-2.
8
Updating the evidence on drugs to treat overactive bladder: a systematic review.
Int Urogynecol J. 2019 Oct;30(10):1603-1617. doi: 10.1007/s00192-019-04022-8. Epub 2019 Jul 25.
9
Gabapentin for chronic neuropathic pain in adults.
Cochrane Database Syst Rev. 2017 Jun 9;6(6):CD007938. doi: 10.1002/14651858.CD007938.pub4.

本文引用的文献

1
Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy.
J Clin Neuromuscul Dis. 2001 Dec;3(2):53-62. doi: 10.1097/00131402-200112000-00002.
2
Pharmacologic management of neuropathic pain: evidence-based recommendations.
Pain. 2007 Dec 5;132(3):237-251. doi: 10.1016/j.pain.2007.08.033. Epub 2007 Oct 24.
3
Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns.
J Clin Epidemiol. 2007 Jul;60(7):651-7; discussion 658-62. doi: 10.1016/j.jclinepi.2006.10.020. Epub 2007 Feb 23.
4
Effects of treatments for symptoms of painful diabetic neuropathy: systematic review.
BMJ. 2007 Jul 14;335(7610):87. doi: 10.1136/bmj.39213.565972.AE. Epub 2007 Jun 11.
5
Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials.
Int J Epidemiol. 2007 Apr;36(2):422-30. doi: 10.1093/ije/dym001. Epub 2007 Feb 14.
7
A simple and valid tool distinguished efficacy from effectiveness studies.
J Clin Epidemiol. 2006 Oct;59(10):1040-8. doi: 10.1016/j.jclinepi.2006.01.011. Epub 2006 Aug 4.
9
Neuropathic pain: a practical guide for the clinician.
CMAJ. 2006 Aug 1;175(3):265-75. doi: 10.1503/cmaj.060146.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验